Desmoplasia: A response or a niche?

Cancer Discovery

Volumn 2, Issue 9, 2012, Pages 772-774

  DeClerck, Yves A ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADALIMUMAB; CD36 ANTIGEN; DEXAMETHASONE; FIBRONECTIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MESSENGER RNA; TAMOXIFEN;

ARTICLE; CANCER RISK; CELL DIFFERENTIATION; CELL INVASION; DESMOPLASIA; EXTRACELLULAR MATRIX; FIBROBLAST; GENE EXPRESSION; GENE REPRESSION; HUMAN; IMMUNE RESPONSE; LIPID STORAGE; MAMMOGRAPHY; NEOPLASM; NONHUMAN; STEM CELL NICHE; STROMA CELL; TUMOR MICROENVIRONMENT;

ANIMALS; ANTIGENS, CD36; BREAST NEOPLASMS; FEMALE; HUMANS; STROMAL CELLS;

EID: 84866325898     PISSN: 21598274     EISSN: 21598290     Source Type: Journal    
DOI: 10.1158/2159-8290.CD-12-0348     Document Type: Article

References (14)

1. Walker RA. The complexities of breast cancer desmoplasia. Breast Cancer Res 2001; 3: 143-5.
2. Barsky SH, Green WR, Grotendorst GR, Liotta LA. Desmoplastic breast carcinoma as a source of human myofibroblasts. Am J Pathol 1984; 115: 329-33.
3. Wolfe JN. Breast patterns as an index of risk for developing breast cancer. Am J Roentgenol 1976; 126: 1130-7.
4. Wolfe JN, Saftlas AF, Slane M. Mammographic parenchymal patterns and quantitative evaluation of mammographic densities: a casecontrol study. Am J Roentgenol 1987; 148: 10887-92.
5. Boyd NF, Martin LUJ, Yaffe MJ, Minkin S. Mammographic density and breast cancer risk: current understanding and future prospects. Breast Cancer Res 2011; 13: 223.
6. Vachon CM, Scott CT, Fasching PA, Hall P, Tamimi RM, Li J, et al. Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer risk. Cancer Epidemiol Biomarkers Prev 2012; 21: 1156-66.
7. DeFilippis RA, Chang H, Dumont N, Rabban JT, Chen Yunn-Yi, Fontenay GV, Berman HK, et al. CD36 repression activates a multicellular stromal program shared by high mammographic density and tumor tissues. Cancer Discov 2012;2:826-39.
8. Harmon CM, Abumrad NA. Binding of sulfosuccinimidyl fatty acids to adipocyte membrane proteins: isolation and amino-terminal sequence of an 88-kD protein implicated in transport of long-chain fatty acids. J Membr Biol 1993; 133: 43-9.
9. Weaver VM, Petersen OW, Wang F, Larabell CA, Briand P, Damsky C, et al. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol 1997; 137: 231-45.
10. Kaplan RN, Rafii S, Lyden D. Preparing the "soil": the premetastatic niche. Cancer Res 2006; 66: 11089-93.
11. Provenzano PP, Inman DR, Eliceiri KW, Knittel JG, Yan L, Rueden CT, et al. Collagen density promotes mammary tumor initiation and progression. BMC Med 2008; 6: 11.
12. Landskroner-Eiger S, Qian B, Muise ES, Narocki AR, Berger JP, Fine EJ, et al. Proangiogenic contribution of adiponectin toward mammary tumor growth in vivo. Clin Cancer Res 2009; 15: 3265-76.
13. Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 2009; 139: 891-906.
14. Tan J, Buache E, Chenard MP, Dali-Youcef N, Rio MC. Adipocyte is a non-trivial, dynamic partner of breast cancer cells. Int J Dev Biol 2011; 55: 851-9.